We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Newborns More Susceptible to Air Pollution

By HospiMedica staff writers
Posted on 21 Jul 2004
A study has revealed that babies in the womb are more susceptible than their mothers to DNA damage from air pollutants. More...
The results were reported in the June 2004 issue of Environmental Health Perspectives.

The purpose of the study was to measure the effects of prenatal and maternal exposure to combustion-related pollutants in New York City (NY, USA), known as polycyclic aromatic hydrocarbons (PAH), on DNA damage. PAHs are carcinogenic air pollutants released into the environment as a result of combustion from car, truck, or bus engines; residential heating; power generation; or tobacco smoking. PAHS are able to cross the placental barrier.

The researchers collected blood samples from 265 pairs of mothers and newborns living in New York City and analyzed them for the presence of two biomarkers: carcinogen-DNA adducts and cotinine. In spite of the estimated 10-fold lower dose of the pollutants to the fetus as compared to the mother, the results showed that levels of DNA were comparable in newborns and mothers, while cotinine levels were higher in newborns than mothers.

"These results raise serious concern,” said study leader Dr. Frederica P. Perera, director of the Columbia Center for Children's Environmental Health, part of the Mailman School of Public Health at Columbia University (New York, NY, USA), which conducted the study. "Fetal susceptibility to DNA damage from air pollution, including motor vehicle emissions and second-hand smoke, has important implications for cancer risk and developmental problems.”




Related Links:
Columbia Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.